C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/24/2002	US6498240 Method for sequencing reaction cleanup by constant pressure diffential ultrafiltration
12/24/2002	US6498239 Sterol glycosyl transferases
12/24/2002	US6498234 Compounds
12/24/2002	US6498233 Nucleic acid transfer system
12/24/2002	US6498147 Suppression of nuclear factor-κb dependent processes using oligonucleotides
12/24/2002	US6498036 Method of replacing a target sequence in a chromosomal gene of a eukaryotic cell, comprising: providing a replacement sequence on a linearized gene-targeting plasmid having ends that are modified to contain a terminating nucleotide analog,
12/24/2002	US6498035 Antisense modulation of MEKK3 expression
12/24/2002	US6498033 Retroviral vector with gag gene sequence containing packaging signal; human immunodeficiency virus treatment; vaccines; gene therapy; anticarcinogenic agents
12/24/2002	US6498027 Virus-like particle or gene delivery vehicle
12/24/2002	US6498026 Variant galactose oxidase, nucleic acid encoding same, and methods of using same
12/24/2002	US6498025 Methods and compositions for cDNA synthesis
12/24/2002	US6498023 Generation of single-strand circular DNA from linear self-annealing segments
12/24/2002	US6498022 Isolated nucleic acid molecules encoding human carbonate transporter proteins, and uses thereof
12/24/2002	US6498020 Fusion proteins comprising coiled-coil structures derived of bovine IF1 ATPase inhibitor protein
12/24/2002	US6498019 Lecithin-cholesterol acyltransferase protein
12/24/2002	US6498018 Cultures of human CNS neural stem cells
12/24/2002	US6498011 Method for transformation of animal cells
12/24/2002	US6498009 β-adrenergic receptor polymorphisms
12/24/2002	US6497884 Viable chimeric recombinant flavivirus comprising region of nucleic acid encoding premembrane and envelope structural proteins of langat virus linked to region of nucleic acid encoding non-structural proteins of dengue type 4 virus
12/24/2002	US6497883 Porcine circovirus recombinant poxvirus vaccine
12/24/2002	US6497882 Virus comprising foreign dna inserted into swinepox virus genome within specified region, which is capable of being expressed in host cell into which virus is introduced
12/24/2002	US6497881 Complex comprising streptavidin-protein a fusion protein having antibody and biotin binding sites, bound antibody specific for cell surface protein, which undergoes endocytosis after binding, bound biotinylated toxin, expressed in cell
12/24/2002	US6497879 Composition which comprises isolated mage-10 tumor rejection antigen precursor which is encoded by nucleic acid having specified nucleotide sequence
12/24/2002	US6497876 Method of stimulating an immune response with activated dendritic cells
12/24/2002	US6497873 Rhabdovirus comprising heterologous fusion protein which facilitates fusion of rhabdovirus to target cell membrane, heterologous g stem polypeptide, rhabdovirus n, p and l proteins, deletion of nucleotide sequence encoding g protein
12/24/2002	US6497872 Neural transplantation using proliferated multipotent neural stem cells and their progeny
12/24/2002	US6497871 Polypeptide having anti-viral and anti-proliferative activity
12/24/2002	CA2153944C Method for the sensitive detection of nucleic acids
12/24/2002	CA2147863C Determination of peptide motifs on mhc molecules
12/24/2002	CA2113907C Apparatus and methods for electroporation amd electrofusion
12/24/2002	CA2087261C Purification directed cloning of peptides
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/24/2002	CA2070182C Chimeric immunoglobulin for cd4 receptors
12/24/2002	CA2065404C Assays and reagents for amyloid deposition
12/24/2002	CA2061636C Chimeric gene for the transformation of plants
12/24/2002	CA2042093C Cell line carrying an excess of mammalian centromeres
12/19/2002	WO2002101357A2 Molecular signatures of commonly fatal carcinomas
12/19/2002	WO2002101356A2 Organellar proteomics including determination of targets for therapeutic intervention identified in the mitochondrial proteome using mass spectrometry
12/19/2002	WO2002101353A2 Methods and products for analyzing nucleic acids based on methylation status
12/19/2002	WO2002101232A2 Bace interacting proteins
12/19/2002	WO2002101095A1 Methods and products for analyzing nucleic acids using nick translation
12/19/2002	WO2002101093A1 Method of determining dna base sequence
12/19/2002	WO2002101092A2 Oligonucleotides for detecting hybridisation
12/19/2002	WO2002101089A2 Method for specific, fast detection of threadlike bacteria
12/19/2002	WO2002101086A2 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
12/19/2002	WO2002101084A2 Scintillation proximity assays for aminoglycoside binding molecules
12/19/2002	WO2002101079A2 Anti-apoptosis genes and methods of use thereof
12/19/2002	WO2002101078A2 Cellulases, nucleic acids encoding them and methods for making and using them
12/19/2002	WO2002101074A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002	WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	WO2002101068A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101067A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101066A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101065A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101064A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101063A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101062A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101061A2 Method for obtaining a monocotyledon plant containing a gene of interest free of foreign ancillary sequence
12/19/2002	WO2002101060A1 Processes and vectors for producing transgenic plants
12/19/2002	WO2002101059A2 Transgenic plants synthesising high amylose starch
12/19/2002	WO2002101058A1 Novel promoter
12/19/2002	WO2002101057A1 Gene transfer into primate embryonic stem cells using vsv-g pseudo type simian immunodeficiency virus vector
12/19/2002	WO2002101056A2 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid
12/19/2002	WO2002101055A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101054A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101053A1 Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system
12/19/2002	WO2002101052A2 Salutaridinol 7-o-acetyltransferase and derivatives thereof
12/19/2002	WO2002101051A2 Genes and proteins for the biosynthesis of anthramycin
12/19/2002	WO2002101050A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/19/2002	WO2002101049A2 Interleukin-18 mutants, their production and use
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101047A1 Method of identifying compounds that modulate epo primary response gene 1, eprg1, activities
12/19/2002	WO2002101046A1 Monoclonal antibody binding to mt4-mmp catalytic domain
12/19/2002	WO2002101045A2 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	WO2002101044A2 Brain expressed gene and protein associated with bipolar disorder
12/19/2002	WO2002101043A2 Regulation of human ta4 receptor
12/19/2002	WO2002101041A1 Method of amplifying nucleic acid and method of detecting nucleotide polymorphism with the use of nucleotide analog
12/19/2002	WO2002101039A1 Method of testing drug for treating or preventing diseases such as hyperlipemia
12/19/2002	WO2002101038A1 Method of constructing host and process for producing foreign protein
12/19/2002	WO2002101036A1 Method of forming stable complex of transcription product of dna encoding arbitrary peptide with translation product, nucleic acid construct to be used in the method, complex formed by the method, and screening of functional protein and mrna or dna encoding the protein using the method
12/19/2002	WO2002101034A1 Leptin-induced gene
12/19/2002	WO2002101032A1 Mutant rna polymerases
12/19/2002	WO2002101031A1 Cyp450-specific dna probes and primers, and biological applications thereof
12/19/2002	WO2002101027A1 Industrially useful microorganisms
12/19/2002	WO2002101026A2 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms
12/19/2002	WO2002101023A2 A method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant
12/19/2002	WO2002101022A2 Method for rapid amplification of dna
12/19/2002	WO2002101021A2 Purification of human serum albumin
12/19/2002	WO2002101019A2 Methods of culturing animal cells and polypeptide production in animal cells
12/19/2002	WO2002101017A2 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
12/19/2002	WO2002101015A2 Integrative assays for monitoring molecular assembly events
12/19/2002	WO2002101013A2 A biological method for the production of alpha-methylene-gamma-butyrolactone and its intermediates
12/19/2002	WO2002101012A2 Regulation of transgene expression following aav transduction
12/19/2002	WO2002101010A2 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
12/19/2002	WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002101006A2 Production of proteins in plants
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002101004A2 Low-temperature cycle extension of dna with high priming specificity
12/19/2002	WO2002101003A2 Stereoselective preparation of cyclic l-amino acids

1 ... 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 ... 4023